| Typicality: | 0.414 |
| Saliency: | 0.384 |
| on the basis of application | 32 | other |
| by application | 6 | other |
| further | 4 | degree |
| market → be segmented into → drug discovery | 34 |
| market → be segmented into → drug development | 10 |
| market → be segmented as → drug discovery | 5 |
| negative | neutral | positive |
| 0.053 | 0.882 | 0.065 |
| Raw frequency | 49 |
| Normalized frequency | 0.384 |
| Modifier score | 0.500 |
| Perplexity | 198.964 |